Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-014888
Filing Date
2024-11-07
Accepted
2024-11-07 16:39:59
Documents
63
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ptgx-20240930x10q.htm   iXBRL 10-Q 1795370
2 EX-31.1 ptgx-20240930xex31d1.htm EX-31.1 10160
3 EX-31.2 ptgx-20240930xex31d2.htm EX-31.2 10150
4 EX-32.1 ptgx-20240930xex32d1.htm EX-32.1 10097
5 GRAPHIC ptgx-20240930x10q006.jpg GRAPHIC 132336
  Complete submission text file 0001558370-24-014888.txt   7075393

Data Files

Seq Description Document Type Size
6 EX-101.SCH ptgx-20240930.xsd EX-101.SCH 44005
7 EX-101.CAL ptgx-20240930_cal.xml EX-101.CAL 59240
8 EX-101.DEF ptgx-20240930_def.xml EX-101.DEF 131186
9 EX-101.LAB ptgx-20240930_lab.xml EX-101.LAB 323577
10 EX-101.PRE ptgx-20240930_pre.xml EX-101.PRE 254682
66 EXTRACTED XBRL INSTANCE DOCUMENT ptgx-20240930x10q_htm.xml XML 1184681
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

EIN.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37852 | Film No.: 241436563
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)